Bring on

The Fight to Cancer

Clinic Study

A clinical trial tested if BAVENCIO® (avelumab) could help patients with MCC who had already received chemotherapy for cancer that had spread to other parts of their body


of patients (29 of 88) saw their tumors get smaller

11% of patients (10 of 88) saw tumors disappear (complete response)

22% of patients (19 of 88) saw tumors shrink (partial response)

Among patients whose tumors got smaller (29 of 88 patients)...

Mcc clinic chart

The minimum duration of this effect was 2.8 months and maximum duration of this effect was over 23.3 months.